MedTrace Logo

Post-ERCP Pancreatitis Prevention by Stent Insertion

NCT01673763 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 169

Last updated 2017-10-13

No results posted yet for this study

Summary

The presented study is designed to analyze the efficacy of pancreatic stent insertion in patients undergoing ERCP with accidental cannulation of the pancreatic duct.

Conditions

  • Post-ERCP Acute Pancreatitis

Interventions

DEVICE

Stent insertion into the main pancreatic duct

Stent insertion into the main pancreatic duct

Sponsors & Collaborators

  • Northern State University, Russia

    collaborator UNKNOWN

  • KU Leuven

    collaborator OTHER

  • Latvijas Universitates Medicinas

    collaborator UNKNOWN

  • Technical University of Munich

    lead OTHER

Principal Investigators

  • Hana Algül, MD, MPH · II. Medizinische Klinik, Klinikum rechts der Isar, Ismaniger Strasse 22, 81675 Munich

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-07-31
Primary Completion
2016-06-30
Completion
2017-08-31

Countries

  • Belgium
  • Germany
  • Latvia
  • Russia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01673763 on ClinicalTrials.gov